There is hope! A drug repurposed for Parkinsons may become a game changer. Dr. Jonathan Sackner-Bernstein is working on a clinical trial (stage 2) for a repurposed drug for Parkinsons patients. He says, and all Parkinson's neurologists know that Parkinsons patients have little dopamine in their brains compared to other people - their "vesicles" can't store dopamine properly. However, in Parkinson's patients they have way too much dopamine in their cells which causes dopamine toxicity which is a problem.
Listen to this video below in order to understand his position and the science...... where he explains it all.
youtube.com/watch?v=Uap1kzI...
Unfortunately this is a repurposed drug so investors may not be interested in funding clinical trials as there isn't enough money in it. Could we start a petition gathering thousands of signatures?